SCHEMBL9890024

SCHEMBL9890024

c1ccc(-c2nc(-c3ccccc3)nc(-c3ccc4oc5c(ccc6c7cc(-c8nc(-c9ccccc9)nc(-c9ccccc9)n8)ccc7oc65)c4c3)n2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.42
▸ ALDH1A1 P00352 5/20 0.42
▸ KMT2A Q03164 5/20 0.42
▸ MEN1 O00255 4/20 0.42
▸ HPGD P15428 3/20 0.42
▸ PLA2G2A P14555 2/20 0.41
▸ PLA2G4A P47712 2/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ PTPRF P10586 3/20 0.39
▸ PTPN2 P17706 3/20 0.39
▸ PTPN1 P18031 3/20 0.39
▸ POLB P06746 3/20 0.39
▸ TSHR P16473 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ PIM1 P11309 1/20 0.39
▸ CSNK2A2 P19784 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19846814 0.97 PLA2G2A (0.43) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL25557579 0.94 ALDH1A1 (0.44) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL21784671 0.91 PLA2G2A (0.46) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL18212395 0.91 MEN1 (0.48) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL25557584 0.91 PLA2G2A (0.46) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL9889977 0.90 KMT2A (0.47) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL1636781 0.89 MEN1 (0.50) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL22879984 0.88 PGR (0.43) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL22329548 0.88 MEN1 (0.43) MAPTALDH1A1KMT2AMEN1HPGD
SCHEMBL24217170 0.88 PLA2G2A (0.49) MAPTALDH1A1KMT2AMEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS IDEMITSU KOSAN CO.,LTD. (JP) 2022-12-29 — — US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 — — US disclosed
US-20120138915-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2012-06-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220416178-A1 COMPOSITION, ORGANIC ELECTROLUMINESCENCE DEVICE, AND ELECTRONIC APPARATUS PIEZO1, TMEM109, SLC39A14 MAPT 1926/4885ALDH1A1 196/4885KMT2A 3009/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback